T Cell Response of Asymptomatic Leishmania chagasi Infected Subjects to Recombinant Leishmania Antigens

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 3, 1999, Pages 367-370

  Costa, Sérgio Ricardo ^a   D'Oliveira Jr , Argemiro ^a   Bacellar, Olívia ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Asymptomatic leishmania chagasi infection; Recombinant leishmania antigens; T cell responses

Indexed keywords

LEISHMANIA DONOVANI CHAGASI;

GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN;

ANIMAL; ARTICLE; BLOOD; CELL DIVISION; CYTOLOGY; HUMAN; IMMUNOLOGY; LEISHMANIA; LEISHMANIASIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, PROTOZOAN; CELL DIVISION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS; T-LYMPHOCYTES;

EID: 0033128314     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000300015     Document Type: Article

References (17)

1. Burns JM, Parsons M, Rosman DE, Reed SG 1993. Molecular cloning and characterization of a 42-kDa protein phosphatase of Leishmania chagasi. J Biol Chem 268: 17155-17161.
2. Burns JM, Scott JM, Carvalho EM, Russo DM, March CJ, Van Ness KP, Reed SG 1991. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol 146: 742-748.
3. Carvalho EM, Bacellar O, Brownell C, Régis T, Coffman RL, Reed SG 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949-5956.
4. Carvalho EM, Badaró R, Reed SG, Jones TC, Johnson WD 1985. Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 76: 2066-2069.
5. Carvalho EM, Barrai A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H, Johnson WD 1992. Immunologic markers of clinical evolution in children recently infected with L. donovani chagasi. J Infect Dis 165: 535-540.
6. D'Oliveira Jr A, Costa SRM, Barbosa AB, Orge MGO, Carvalho EM 1997. Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz 92: 15-20.
7. Ghalib HW, Piuvezam M, Skeiky Y, Siddig M, Hashim F, Russo C, Reed S 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92: 324-329.
8. Grimaldi G Jr, Tesh RB, McMahon-Pratt D 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am J Trop Med Hyg 41: 687-725.
9. Horwitz JG, Garret M 1977. A distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes and monocytes. J Immunol 118: 1712-1721.
10. Jerônimo SMB, Oliveira RM, Mackay S, Costa RM, Sweet J, Nascimento ET, Luz KG, Fernandes MZ, Jernigan J, Pearson RD 1994. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg 88: 386-388.
11. MacFarlane J, Blaxter ML, Bishop RP, Miles MA, Kelly JM 1990. Identification and characterization of a Leishmania donovani antigen belonging to the 70-kDa heat-shock protein family. Eur J Biochem 190: 377-384.
12. Murray HW, Rubin BY, Rothermel CD 1983. Killing of intracellular L. donovani by lymphokine stimulated human mononuclear phagocytes. Evidence that interferon gamma is the activating lymphokine. J Clin Invest 72: 1506-1510.
13. Reed SG, Carvalho EM, Sherbert CH, Pedral-Sampaio D, Russo DM, Bacellar O, Pihl DL, Scott JM, Barral A, Grabstein KH, Johnson WD 1990. In vitro responses to leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J Clin Invest 85: 690-696.
14. Russo DM, Turco SJ, Burns JM, Reed SG 1992. Stimulation of human T cell lymphocytes by leishmania lipophosphoglycan-associated protein. J Immunol 148: 202-207.
15. Russo DM, Burns JM, Carvalho EM, Armitage RJ, Grabstein KH, Button LL, McMaster WR, Reed SG 1991. Human T cell responses to gp63 a surface antigen of leishmania. J Immunol 147: 3575-3580.
16. Shreffler WG, Burns Jr JM, Badaró R, Ghalib HW, Button LL, McMaster WR, Reed SG 1993. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis 167: 426-430.
17. Skeiky YAW, Guderian JA, Benson DR, Bacellar O, Carvalho EM, Kubin M, Badaró R, Trinchieri G, Reed SG 1995. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med 181: 1527-1537.